| Literature DB >> 30787130 |
Erin Reid1, Gita Suneja2, Richard F Ambinder3, Kevin Ard4, Robert Baiocchi5, Stefan K Barta6, Evie Carchman7, Adam Cohen8, Oxana V Crysler9, Neel Gupta10, Chelsea Gustafson11, Allison Hall2, Kimberly L Johung12, Ann Klopp13, Ann S LaCasce14, Chi Lin15, Amitkumar Mehta16, Manoj P Menon17, David Morgan18, Nitya Nathwani19, Ariela Noy20, Lee Ratner21, Stacey Rizza22, Michelle A Rudek3, Julian Sanchez23, Jeff Taylor24, Benjamin Tomlinson25, Chia-Ching J Wang26, Sai Yendamuri27, Mary A Dwyer, Deborah A Freedman-Cass28.
Abstract
As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin's lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease.Entities:
Year: 2019 PMID： 30787130 DOI： 10.6004/jnccn.2019.0008
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908